Skip to main content
. Author manuscript; available in PMC: 2021 Dec 9.
Published in final edited form as: J Asthma. 2020 Jan 6;58(4):471–480. doi: 10.1080/02770903.2019.1709867

Table 4.

Conditional logistic regression: univariate analysis.

Unadjusted point estimatea
Covariates Point estimate 95% CI P valuea
Race(ref = other) NA NA NAa
Height (cm) 0.98 0.88,1.10 0.74
Weight (kg) 0.88 0.68,1.15 0.36
BSA NA NA NA a
BMI 0.86 0.63,1.18 0.34
Temperature in arrival (C) 0.43 0.12,1.49 0.18
Respiratory rate 1.002 0.93,1.08 0.96
Heart rate 1.07 0.99,1.14 0.08
Total dose levalbuterol given in ED and hospital (mg) 2.001 0.901,4.44 0.09
Levalbuterol doses 1.55 0.94,2.56 0.09
Total dose of albuterol in ED and hospital (mg) 0.997 0.99,1.01 0.66
Albuterol doses 0.994 0.97,1.02 0.66
Levalbuterol plus albuterol doses 0.995 0.97,1.02 0.70
Beta agonist doses/time 2.38 0.99,5.75 0.053
Number of chronic asthma control medications 0.91 0.40,2.07 0.81
Number of days of illness prior to presentation 0.47 0.18,1.25 0.13
Use albuterol at home(ref = no) 0.15 0.017,1.31 0.08
Use levalbuterol at home(ref = no) NA NA NAa
History of diagnosed asthma(ref = no) 0.59 0.11,3.15 0.54
History of documented SVT(ref = no) NA NA NAa
Family history of arrhythmia(ref = no) NA NA NAa
History of CHD(ref = no) 1.62 0.14,18.63 0.70

Note: conditional logistic regression is conducted to evaluate the likelihood of having SVT.

a

The model was not converged due to insufficient sample size of case.